News from transcept pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 01, 2014, 06:15 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals and Paratek Pharmaceuticals Sign Merger Agreement

 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) and Paratek Pharmaceuticals, Inc., a privately-held biopharmaceutical company, announced today...

May 14, 2014, 08:00 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Declares Special Cash Dividend Of $25 Million

 Transcept Pharmaceuticals Inc. (NASDAQ: TSPT) announced today that its board of directors declared a special cash dividend of $1.33 per...

May 05, 2014, 16:05 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Reports First Quarter 2014 Financial Results

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary...

Mar 13, 2014, 16:05 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary...

Jan 13, 2014, 18:30 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Statement on Dismissal of Derivative Lawsuit

 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced the dismissal of the derivative lawsuit by the Court of Chancery of the State...

Dec 19, 2013, 17:27 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Final Voting Results for Special Meeting of Stockholders Provide Strong Support for Current Board of Directors and Tax Benefit Preservation Program

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that, based upon the final vote count certified by the independent inspector of...

Dec 17, 2013, 16:15 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Statement on the Withdrawal of the Unsolicited Indication of Interest from Retrophin, Inc.

 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today commented on the recent announcements from Retrophin, Inc. that it has withdrawn its...

Dec 16, 2013, 22:45 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Announces That Largest Stockholder, Roumell Asset Management, Declares Support Of Company Strategies

 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of...

Dec 13, 2013, 16:49 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Announces that Glass Lewis & Co. Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that Glass Lewis & Co. ("Glass Lewis"), an independent proxy voting and...

Dec 11, 2013, 16:36 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Announces that ISS Proxy Advisory Services Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders

 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that ISS Proxy Advisory Services ("ISS"), a leading independent proxy...

Dec 04, 2013, 20:57 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Provides Update to Key Initiatives Being Undertaken to Increase Stockholder Value

 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of...

Nov 13, 2013, 07:30 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Announces Plans to Reduce Expenses Through a Reduction in Force and a Restructuring of its Board of Directors

 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of...

Nov 07, 2013, 16:05 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Reports Third Quarter Financial Results

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary...

Nov 04, 2013, 16:15 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals to Report Third Quarter 2013 Financial Results and Host Conference Call on November 7, 2013

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary...

Oct 07, 2013, 07:30 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Sets Special Stockholders Meeting

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) announced today that it will hold a special meeting of stockholders on December 19, 2013.  The...

Sep 30, 2013, 08:40 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Statement on Request by Retrophin, Inc. to Acquire Up To 15 Percent of the Outstanding Common Stock of Transcept

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) today announced that it had received a communication from Retrophin, Inc. stating that it owns 4.9%...

Sep 25, 2013, 16:14 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept And Shin Nippon Biomedical Laboratories Announce Global Licensing Agreement For Advanced Acute Migraine Treatment

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT), and Shin Nippon Biomedical Laboratories, Ltd ("SNBL"), today announced that the companies have...

Sep 25, 2013, 16:05 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Statement on Unsolicited Acquisition Proposal from Retrophin, Inc.

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) today announced that it has rejected an unsolicited proposal from Retrophin, Inc. to acquire all of...

Sep 13, 2013, 16:01 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals, Inc. Adopts Tax Benefit Preservation Plan

 Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) announced today that its Board of Directors has adopted a tax benefit preservation plan to help...

Aug 07, 2013, 16:05 ET
Transcept Pharmaceuticals, Inc. logo.  (PRNewsFoto/Transcept Pharmaceuticals, Inc.)

Transcept Pharmaceuticals Reports Second Quarter Financial Results

 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization...